[1]赵予涵,林燕铭,谭艳芬.高值医用耗材治理背景下老年性白内障手术费用研究[J].卫生经济研究,2022,39(1):40-43.
　ZHAO Yu-han,LIN Yan-ming,TAN Yan-fen.Study on the Cost of Senile Cataract Surgery Under the High-value Medical Consumables Governance[J].Journal Press of Health Economics Research,2022,39(1):40-43.
点击复制

高值医用耗材治理背景下老年性白内障手术费用研究
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
39
期数:
2022年1期
页码:
40-43
栏目:
疾病经济负担
出版日期:
2022-01-07

文章信息/Info

Title:
Study on the Cost of Senile Cataract Surgery Under the High-value Medical Consumables Governance
作者:
赵予涵1; 林燕铭2; 谭艳芬1
1.北京大学第一医院，北京 100034
2.北京大学公共卫生学院，北京 100191
Author(s):
ZHAO Yu-han;  LIN Yan-ming;  TAN Yan-fen
Peking University First Hospital, Beijing 100034, China
关键词:
零差率; 集中带量采购; 老年性白内障; 人工晶体置入术; 高值医用耗材治理
Keywords:
zero-markup rate;  centralized volume-based procuremen;  senile cataract;  intraocular lens implantation;  high-value medical consumables governance
分类号:
R197.3
文献标志码:
B
摘要:
目的:探讨医用耗材零差率和集中带量采购政策对白内障手术费用的影响。方法:通过统计分析，比较样本医院三个时期（基线期、零差率期和带量采购期）老年性白内障手术患者的医疗费用，并进行定性访谈。结果：三个时期老年性白内障手术患者的总医疗费用、医疗服务费、耗材费和药品费的差异有统计学意义（均为P<0.001）；零差率和集中带量采购政策有效降低了老年性白内障患者的医疗费用，节约了医保资金支出，且集中带量采购政策的作用更显著。结论：未来配合DRG付费制度改革，要建立有效的监督评价体系，完善医疗机构绩效分配机制，使结余留用资金真正起到规范医疗行为的激励作用。
Abstract:
Objective To explore the effects of zero-markup rate of medical consumables and centralized volume-based procurement policy on cataract surgery costs. Methods Through statistical analysis, the medical costs of senile cataract surgery patients in the sample hospitals were compared in three periods (baseline period, zero-markup period and volume purchase period), and qualitative interviews were conducted. Results There were statistically significant differences in the total medical costs, medical service costs, consumables costs and drug costs of senile cataract patients in the three periods (all P<0.001). The zero-markup rate and centralized volume-based procuremen policy effectively reduced the medical costs of senile cataract patients, saved medical insurance expenditure, and the effect of centralized volume-based procuremen policy was more significant. Conclusion In the future, cooperating with DRG payment system reform, it is necessary to establish an effective supervision and evaluation system, improve the performance distribution mechanism of medical institutions, so that the remaining funds can truly play an incentive role in standardizing medical behavior.

参考文献/References:

[1] Causes of blindness and vision impairment in 2020 and trends over 30 years,and prevalence of avoidable blindness in relation to VISION 2020:the Right to Sight: an analysis for the Global Burden of Disease Study[J].Lancet Glob Health, 2021,9(2):e144-e160.
[2] Song P,Wang H,Theodoratou E,et al.The national and subnational prevalence of cataract and cataract blindness in China:a systematic review and meta-analysis[J].J Glob Health, 2018,8(1):10804.
[3] Ramke J,Petkovic J,Welch V,et al.Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries[J].Cochrane Database Syst Rev, 2017（11）:D11307.
[4] 国家卫生健康委员会. 中国卫生健康统计年鉴[M]. 北京：中国协和医科大学出版社，2020.
[5] 李国田. “3+N”医用耗材采购联盟集中带量采购的实践与思考[J].中国医疗保险，2020（9）：7-8.
[6]北京市医疗保障局北京市卫生健康委员会北京市药品监督管理局关于印发北京市落实京津冀医用耗材联合带量采购(人工晶体类)工作实施方案的通知[Z].北京市人民政府公报，2020（42）：76-81.
[7] 郑天玉，卢奕.从新版美国眼科临床指南(PPP)看成人白内障手术的意义与指征[J].中国眼耳鼻喉科杂志，2018，18（5）：301-304.
[8] 买尔哈巴·米吉提，沈丹妮，凯迪丽亚·阿力甫，等.2010-2018年新疆白内障手术状况分析[J].眼科，2020，29（4）：294-297.
[9] 曾琦，杨梅，詹磊磊，等.2013年中国白内障复明手术信息报告系统中医疗机构和手术费用信息研究[J].中国医院，2016，20（5）：35-36.
[10] 王沛陵，郑杰，贾方红，等.北京市单病种付费政策回顾性研究[J].中国医院管理，2017，37（8）：10-12.
[11] 顾昕.医保支付改革中国探索的历史回顾与反思——以按疾病诊断组（DRGs）支付为案例[J].中国医院院长，2020（12）：65-75.

相似文献/References:

[1]陈新平.药品及耗材零差率改革对省级医院运行的影响与对策[J].卫生经济研究,2016,(05):42.
[2]郑洋洋,丁锦希,李佳明,等.高值耗材实施集中带量采购的主要障碍及对策研究[J].卫生经济研究,2021,38(4):35.
　ZHENG Yang-yang,DING Jin-xi,LI Jia-ming,et al.Research on the Main Obstacles and Countermeasures of Centralized Quantity Purchase of High Value Medical Consumables[J].Journal Press of Health Economics Research,2021,38(1):35.
[3]周菁菁,谈在祥.国家组织冠脉支架集中带量采购的实施情况及建议[J].卫生经济研究,2021,38(11):3.
　ZHOU Jing-jing,TAN Zai-xiang.Implementation and Suggestions of Centralized Volume-based Procurement of Coronary Stent by National Organization[J].Journal Press of Health Economics Research,2021,38(1):3.
[4]冷楠楠,邱英鹏,赵羽西,等.冠脉支架集中带量采购对医疗服务供给的潜在影响分析[J].卫生经济研究,2022,39(5):1.
　LEN Nan-nan,QIU Ying-peng,ZHAO Yu-xi,et al.Analysis of the Potential Impact of the Policy of Centralized Procurement of Coronary Stents on the Provision of Medical Services[J].Journal Press of Health Economics Research,2022,39(1):1.
[5]蒋范黎,肖 月,赵羽西,等.集采背景下经皮冠脉支架植入术成本测算及建议[J].卫生经济研究,2022,39(5):4.
　JIANG Fan-li,XIAO Yue,ZHAO Yu-xi,et al.The Cost Calculation and Analysis of Percutaneous Coronary Intervention under the Background of Centralized Procurement of Stents[J].Journal Press of Health Economics Research,2022,39(1):4.
[6]罗婷婷,王秀英,吴伟旋,等.医院不计价及打包收费耗材的管理现状及对策[J].卫生经济研究,2022,39(5):91.
　LUO Ting-ting,WANG Xiu-ying,WU Wei-xuan,et al.Management Status and Improvement Suggestions of Non-priced and Packaged Charging Consumables[J].Journal Press of Health Economics Research,2022,39(1):91.
[7]黄晓青,王煜昊,王丽娜,等.医用耗材集采背景下按病种分值付费优化方案研究 ——以冠状动脉支架为例[J].卫生经济研究,2022,39(10):16.
　HUANG Xiaoqing,WANG Yuhao,WANG Lina,et al.Research on Policy Optimization of Diagnosis-Intervention Packet Based the Volume-Based Procurement of Medical Comsumables ——Taking Coronary Stents as an Example[J].Journal Press of Health Economics Research,2022,39(1):16.
[8]孙李丽,毛 英,张馨怡,等.国家集中带量采购冠脉支架对住院费用的影响研究[J].卫生经济研究,2023,40(5):55.
　SUN Lili,MAO Ying,ZHANG Xinyi,et al.Study on the Effect of National Centralized Volume-based Procurement of Coronary Stents on Hospitalization Costs[J].Journal Press of Health Economics Research,2023,40(1):55.
[9]李 洁,周胜男,孙源源.基于政策工具理论的中成药集中带量采购政策设计研究[J].卫生经济研究,2023,40(6):13.
　LI Jie,ZHOU Shengnan,SUN Yuanyuan.Study on the Policy Design of Centralized Volume-based Procurement of Chinese Patent Medicine Based on the Policy Tools Theory[J].Journal Press of Health Economics Research,2023,40(1):13.
[10]徐露露,张 钿,陈井婵,等.医保战略性购买对医药企业创新的影响研究[J].卫生经济研究,2023,40(12):7.
　XU Lulu,ZHANG Tian,CHEN Jingchan,et al.Study on the Impact of Strategic Purchase of Medical Insurance on Innovation of Pharmaceutical Enterprises[J].Journal Press of Health Economics Research,2023,40(1):7.

更新日期/Last Update: 2022-01-07